跳至主要内容
临床试验/ITMCTR1900002659
ITMCTR1900002659招募中未知

hypoxia-inducible factor-1 alpha is a key regulator of angiogenesis and inflammation in rheumatoid arthritis: a case-control study

Shanghai Traditional Medicine University Affiliated Guanghua Hospital0 个研究点开始时间: 待定最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方

研究概览

简要总结

暂无简介。

研究设计

研究类型
Basic Science

入排标准

年龄范围
60 至 75(—)
性别
Female

入选标准

  • Criteria for RA:
  • (1) patients with definite diagnosis of rheumatoid arthritis;
  • (2) patients have no serious primary diseases, chronic wasting diseases and mental disorders such as cardiac, cerebrovascular, liver, kidney and hematopoietic system;
  • (3) patients with knee joint pain accompanied by destruction need knee joint replacement;
  • (4) patients have better compliance and can complete the whole course of treatment.

排除标准

  • (1) the patients refused to undergo knee replacement;
  • (2) the patients have surgical contraindications;
  • (3) those with poor compliance or who are participating in other drug trials;
  • (4) patients who have not been treated with this test protocol as required.

研究者

发起方
Shanghai Traditional Medicine University Affiliated Guanghua Hospital

相似试验